目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Peptide Therapeutics Market Variables, Trends, & Scope
3.1. Parent Market Outlook
3.2. Ancillary Market Outlook
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.1.1. Increasing prevalence of cancer
3.3.1.1.1. Cancer incidence data
3.3.1.2. Technological advancements
3.3.1.3. Presence of strong product pipeline
3.3.2. Market Restraints Analysis
3.3.2.1. Increasing complexity of peptides
3.3.2.2. High cost of manufacturing equipment
3.4. Peptide Therapeutics Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
3.5. Pipeline Analysis
3.5.1. Phase 1
3.5.2. Phase 2
3.5.3. Phase 3
3.6. Phase 3 Pipeline Drug Forecasts
3.7. Case Studies Analysis

Chapter 4. Peptide Therapeutics Market: By Application Estimates & Trend Analysis
4.1. Peptide Therapeutics Market: Application Segment Dashboard
4.2. Peptide Therapeutics Market: By Application Movement Analysis, 2024 & 2030 (USD Million)
4.3. Metabolic Disorders
4.3.1. Metabolic Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Cancer
4.4.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Neurological Disorders
4.5.1. Neurological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Gastrointestinal Disorders
4.6.1. Gastrointestinal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Cardiovascular Disorders
4.7.1. Cardiovascular Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Pain
4.8.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Infectious Disease
4.9.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.10. Renal Disorders
4.10.1. Renal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.11. Dermatological Disorders
4.11.1. Dermatological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.12. Respiratory Disorders
4.12.1. Respiratory Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.13. Others
4.13.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Peptide Therapeutics Market: Type Estimates & Trend Analysis
5.1. Peptide Therapeutics Market: Type Segment Dashboard
5.2. Peptide Therapeutics Market: By Type Movement Analysis, 2024 & 2030 (USD Million)
5.3. Innovative
5.3.1. Innovative Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Generic
5.4.1. Generic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Peptide Therapeutics Market: Type of Manufacturer Estimates & Trend Analysis
6.1. Peptide Therapeutics Market: Type of Manufacturer Segment Dashboard
6.2. Peptide Therapeutics Market: By Type of Manufacturer Movement Analysis, 2024 & 2030 (USD Million)
6.3. Inhouse
6.3.1. Inhouse Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Outsourced
6.4.1. Outsourced Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Peptide Therapeutics Market: Synthesis Technology Estimates & Trend Analysis
7.1. Peptide Therapeutics Market: Synthesis Technology Segment Dashboard
7.2. Peptide Therapeutics Market: Synthesis Technology Movement Analysis, 2024 & 2030 (USD Million)
7.3. Recombinant DNA Technology
7.3.1. Recombinant DNA Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Solid-Phase Peptide Synthesis (SPPS)
7.4.1. Solid-Phase Peptide Synthesis (SPPS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Hybrid
7.5.1. Hybrid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Liquid-Phase Peptide Synthesis (LPPS)
7.6.1. Liquid-Phase Peptide Synthesis (LPPS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Others
7.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Peptide Therapeutics Market: Route of Administration Estimates & Trend Analysis
8.1. Peptide Therapeutics Market: Route of Administration Segment Dashboard
8.2. Peptide Therapeutics Market: Route of Administration Movement Analysis, 2024 & 2030 (USD Million)
8.3. Parenteral Route
8.3.1. Parenteral Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Oral Route
8.4.1. Oral Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Mucosal
8.5.1. Mucosal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Pulmonary
8.6.1. Pulmonary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Others
8.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Peptide Therapeutics Market: Regional Estimates & Trend Analysis
9.1. Peptide Therapeutics Market Share, By Region, 2024 & 2030, USD Million
9.2. North America
9.2.1. North America Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Target Disease Prevalence
9.2.2.3. Regulatory Framework
9.2.2.4. Reimbursement Framework
9.2.2.5. U.S. Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Prevalence
9.2.3.3. Regulatory Framework
9.2.3.4. Reimbursement Framework
9.2.3.5. Canada Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.4. Mexico
9.2.4.1. Key Country Dynamics
9.2.4.2. Target Disease Prevalence
9.2.4.3. Regulatory Framework
9.2.4.4. Reimbursement Framework
9.2.4.5. Mexico Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. Europe Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.2. UK
9.3.2.1. Key Country Dynamics
9.3.2.2. Target Disease Prevalence
9.3.2.3. Regulatory Framework
9.3.2.4. Reimbursement Framework
9.3.2.5. Uk Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Regulatory Framework
9.3.3.4. Reimbursement Framework
9.3.3.5. Germany Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Regulatory Framework
9.3.4.4. Reimbursement Framework
9.3.4.5. France Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Prevalence
9.3.5.3. Regulatory Framework
9.3.5.4. Reimbursement Framework
9.3.5.5. Italy Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Prevalence
9.3.6.3. Regulatory Framework
9.3.6.4. Reimbursement Framework
9.3.6.5. Spain Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Prevalence
9.3.7.3. Regulatory Framework
9.3.7.4. Reimbursement Framework
9.3.7.5. Denmark Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Prevalence
9.3.8.3. Regulatory Framework
9.3.8.4. Reimbursement Framework
9.3.8.5. Sweden Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Prevalence
9.3.9.3. Regulatory Framework
9.3.9.4. Reimbursement Framework
9.3.9.5. Norway Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Target Disease Prevalence
9.4.2.3. Regulatory Framework
9.4.2.4. Reimbursement Framework
9.4.2.5. Japan Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Regulatory Framework
9.4.3.4. Reimbursement Framework
9.4.3.5. China Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Regulatory Framework
9.4.4.4. Reimbursement Framework
9.4.4.5. India Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.5. Australia
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Regulatory Framework
9.4.5.4. Reimbursement Framework
9.4.5.5. Australia Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Regulatory Framework
9.4.6.4. Reimbursement Framework
9.4.6.5. South Korea Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Regulatory Framework
9.4.7.4. Reimbursement Framework
9.4.7.5. Thailand Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Target Disease Prevalence
9.5.2.3. Regulatory Framework
9.5.2.4. Reimbursement Framework
9.5.2.5. Japan Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.3. Argentina
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Regulatory Framework
9.5.3.4. Reimbursement Framework
9.5.3.5. China Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa Peptide Therapeutics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
9.6.2. South Africa
9.6.2.1. Key Country Dynamics
9.6.2.2. Target Disease Prevalence
9.6.2.3. Regulatory Framework
9.6.2.4. Reimbursement Framework
9.6.2.5. South Africa Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Regulatory Framework
9.6.3.4. Reimbursement Framework
9.6.3.5. Saudi Arabia Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Prevalence
9.6.4.3. Regulatory Framework
9.6.4.4. Reimbursement Framework
9.6.4.5. UAE Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Prevalence
9.6.5.3. Regulatory Framework
9.6.5.4. Reimbursement Framework
9.6.5.5. Kuwait Peptide Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Participant Overview
10.4. Financial Performance
10.5. Product Bench Marking
10.6. Company Market Share Analysis, 2024
10.7. Company Profiles
10.7.1. Eli Lilly and Company
10.7.1.1. Participant’s Overview
10.7.1.2. Financial Performance
10.7.1.3. Product Benchmarking
10.7.1.4. Recent Developments/ Strategic Initiatives
10.7.2. Pfizer Inc.
10.7.2.1. Participant’s Overview
10.7.2.2. Financial Performance
10.7.2.3. Product Benchmarking
10.7.2.4. Recent Developments/ Strategic Initiatives
10.7.3. Amgen Inc.
10.7.3.1. Participant’s Overview
10.7.3.2. Financial Performance
10.7.3.3. Product Benchmarking
10.7.3.4. Recent Developments/ Strategic Initiatives
10.7.4. Takeda Pharmaceutical Company Limited
10.7.4.1. Participant’s Overview
10.7.4.2. Financial Performance
10.7.4.3. Product Benchmarking
10.7.4.4. Recent Developments/ Strategic Initiatives
10.7.5. AstraZeneca
10.7.5.1. Participant’s Overview
10.7.5.2. Financial Performance
10.7.5.3. Product Benchmarking
10.7.5.4. Recent Developments/ Strategic Initiatives
10.7.6. Teva Pharmaceutical Industries Ltd.
10.7.6.1. Participant’s Overview
10.7.6.2. Financial Performance
10.7.6.3. Product Benchmarking
10.7.6.4. Recent Developments/ Strategic Initiatives
10.7.7. Sanofi
10.7.7.1. Participant’s Overview
10.7.7.2. Financial Performance
10.7.7.3. Product Benchmarking
10.7.7.4. Recent Developments/ Strategic Initiatives
10.7.8. F. Hoffmann-La Roche Ltd
10.7.8.1. Participant’s Overview
10.7.8.2. Financial Performance
10.7.8.3. Product Benchmarking
10.7.8.4. Recent Developments/ Strategic Initiatives
10.7.9. Novartis AG
10.7.9.1. Participant’s Overview
10.7.9.2. Financial Performance
10.7.9.3. Product Benchmarking
10.7.9.4. Recent Developments/ Strategic Initiatives
10.7.10. Novo Nordisk A/S
10.7.10.1. Participant’s Overview
10.7.10.2. Financial Performance
10.7.10.3. Product Benchmarking
10.7.10.4. Recent Developments/ Strategic Initiatives
10.7.11. GSK plc
10.7.11.1. Participant’s Over
10.7.11.2. Financial Performance
10.7.11.3. Product Benchmarking
10.7.11.4. Recent Developments/ Strategic Initiatives
10.7.12. Ironwood Pharmaceuticals, Inc.
10.7.12.1. Participant’s Overview
10.7.12.2. Financial Performance
10.7.12.3. Product Benchmarking
10.7.12.4. Recent Developments/ Strategic Initiatives
10.7.13. Radius Health, Inc. (Subsidiary of Gurnet Point Capital and Patient Square Capital)
10.7.13.1. Participant’s Overview
10.7.13.2. Financial Performance
10.7.13.3. Product Benchmarking
10.7.13.4. Recent Developments/ Strategic Initiatives
10.7.14. Ipsen Pharma
10.7.14.1. Participant’s Overview
10.7.14.2. Financial Performance
10.7.14.3. Product Benchmarking
10.7.14.4. Recent Developments/ Strategic Initiatives

Chapter 11. Conclusion/Key Takeaways/KoL Insights

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 4 North America peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 5 North America peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 6 North America peptide therapeutics market estimates and forecasts, by type of manufacturer, 2018 - 2030 (USD Million)
Table 7 North America peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 8 North America peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 9 U.S. peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 10 U.S. peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 11 U.S. peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 12 U.S. peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 13 U.S. peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 14 Canada peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 15 Canada peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 16 Canada peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 17 Canada peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 18 Canada peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 19 Mexico peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 20 Mexico peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 21 Mexico peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 22 Mexico peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 23 Mexico peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 24 Europe peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 25 Europe peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 26 Europe peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 27 Europe peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 28 Europe peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 29 Europe peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 30 UK peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 31 UK peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 32 UK peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 33 UK peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 34 UK peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 35 Germany peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 36 Germany peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 37 Germany peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 38 Germany peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 39 Germany peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 40 France peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 41 France peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 42 France peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 43 France peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 44 France peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 45 Spain peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 46 Spain peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 47 Spain peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 48 Spain peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 49 Spain peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 50 Italy peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 51 Italy peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 52 Italy peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 53 Italy peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 54 Italy peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 55 Denmark peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 56 Denmark peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 57 Denmark peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 58 Denmark peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 59 Denmark peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 60 Sweden peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 61 Sweden peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 62 Sweden peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 63 Sweden peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 64 Sweden peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 65 Norway peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 66 Norway peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 67 Norway peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 68 Norway peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 69 Norway peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 70 Asia Pacific peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 71 Asia Pacific peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 72 Asia Pacific peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 73 Asia Pacific peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 74 Asia Pacific peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 75 Asia Pacific peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 76 Japan peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 77 Japan peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 78 Japan peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 79 Japan peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 80 Japan peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 81 China peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 82 China peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 83 China peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 84 China peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 85 China peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 86 India peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 87 India peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 88 India peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 89 India peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 90 India peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 91 South Korea peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 92 South Korea peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 93 South Korea peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 94 South Korea peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 95 South Korea peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 96 Australia peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 97 Australia peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 98 Australia peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 99 Australia peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 100 Australia peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 101 Thailand peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 102 Thailand peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 103 Thailand peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 104 Thailand peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 105 Thailand peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 106 Latin America peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 107 Latin America peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 108 Latin America peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 109 Latin America peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 110 Latin America peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 111 Latin America peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 112 Brazil peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 113 Brazil peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 114 Argentina peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 115 Argentina peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 116 Argentina peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 117 Argentina peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 118 Argentina peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 119 MEA peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 120 MEA peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 121 MEA peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 122 MEA peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 123 MEA peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 124 MEA peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 125 South Africa peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 126 South Africa peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 127 South Africa peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 128 South Africa peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 129 South Africa peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 130 UAE peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 131 UAE peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 132 UAE peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 133 UAE peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 134 UAE peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 136 Saudi Arabia peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 137 Saudi Arabia peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 140 Kuwait peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 141 Kuwait peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 142 Kuwait peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 143 Kuwait peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 144 Kuwait peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)
Table 145 Kuwait peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Million)
Table 146 Kuwait peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
Table 147 Kuwait peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Peptide therapeutics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Application segment snapshot
Fig. 10 Type and type of manufacturers segment snapshot
Fig. 11 Route of administration and synthesis technology segment snapshot
Fig. 12 Competitive landscape snapshot
Fig. 13 Pharmaceutical market, (USD Billion)
Fig. 14 Market dynamics
Fig. 15 The most common cancers globally are listed in the table below
Fig. 16 Global number of new cases caused by top 11 cancer types in 2023 (in thousands)
Fig. 17 The figure below shows the phase of therapeutic peptides in clinical trials
Fig. 18 Porter’s five forces analysis
Fig. 19 PESTLE analysis
Fig. 20 Peptide therapeutics market: Application outlook and key takeaways
Fig. 21 Peptide therapeutics market: Application movement analysis
Fig. 22 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Metabolic disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Cardiovascular disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Respiratory disorders market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Gastrointestinal disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Pain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Dermatological disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Renal disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Peptide therapeutics market: Type outlook and key takeaways
Fig. 34 Peptide therapeutics market: Type movement analysis
Fig. 35 Generic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Innovative market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Peptide therapeutics market: Type of manufacturers outlook and key takeaways
Fig. 38 Peptide therapeutics market: Type of manufacturers movement analysis
Fig. 39 In-house market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Outsourced market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Peptide therapeutics market: Route of administration outlook and key takeaways
Fig. 42 Peptide therapeutics market: Route of administration movement analysis
Fig. 43 Parenteral route market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Oral route market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Pulmonary market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Mucosal market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Peptide therapeutics market: Synthesis technology outlook and key takeaways
Fig. 49 Peptide therapeutics market: Synthesis technology movement analysis
Fig. 50 Solid Phase Peptide Synthesis (SPPS) market estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 51 Recombinant DNA technology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Hybrid technology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Liquid-Phase Peptide Synthesis (LPPS) technology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Peptide therapeutics market revenue, by region, 2024 & 2030, (USD Million)
Fig. 56 Regional marketplace: Key takeaways
Fig. 57 Regional marketplace: Key takeaways
Fig. 58 North America peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Target disease prevalence
Fig. 61 U.S. peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Target disease prevalence
Fig. 64 Canada peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Mexico peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Target disease prevalence
Fig. 68 Europe peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Target disease prevalence
Fig. 71 UK peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Target disease prevalence
Fig. 74 Germany peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Target disease prevalence
Fig. 77 France peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Target disease prevalence
Fig. 80 Spain peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Target disease prevalence
Fig. 83 Italy peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Target disease prevalence
Fig. 86 Denmark peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 Target disease prevalence
Fig. 89 Sweden peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 Target disease prevalence
Fig. 92 Norway peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Rest of Europe peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Asia Pacific peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 Target disease prevalence
Fig. 97 Japan peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Target disease prevalence
Fig. 100 China peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Key country dynamics
Fig. 102 Target disease prevalence
Fig. 103 India peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 Key country dynamics
Fig. 105 Target disease prevalence
Fig. 106 Australia peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Thailand peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 109 Key country dynamics
Fig. 110 South Korea peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 111 Rest of Asia Pacific peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 112 Latin America peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 113 Key country dynamics
Fig. 114 Target disease prevalence
Fig. 115 Brazil peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 116 Key country dynamics
Fig. 117 Target disease prevalence
Fig. 118 Argentina peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 119 Rest of Latin America peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 120 MEA peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 121 Key country dynamics
Fig. 122 Target disease prevalence
Fig. 123 South Africa peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 124 Key country dynamics
Fig. 125 Target disease prevalence
Fig. 126 Saudi Arabia peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 127 Key country dynamics
Fig. 128 Target disease prevalence
Fig. 129 UAE peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 130 Key country dynamics
Fig. 131 Target disease prevalence
Fig. 132 Kuwait peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 133 Rest of MEA peptide therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)